Companies moot ₹5,445 crore projects, creation of 9,800 jobs at Green Pharma City near Hyderabad

A clutch of investment announcements, particularly ₹5,445 crore in Green Pharma City, partnerships to advance the Life Sciences ecosystem in Telangana and business collaborations were made at BioAsia 2025 held in Hyderabad on Monday (February 2025).

The 11 companies committed to create 9,800 jobs

Granules, Orbicular, Aizant, Biological E, Virchow, Virupaksha, Jubilant, Vimta, Aragen, Bharat Biotech and Sai Life Sciences are the 11 companies that committed to invest ₹5,445 crore and creation of 9,800 job at the Green Pharma City, coming up near Hyderabad. The MoU they signed are in addition to the six other pharma companies that have already signed with the State government, Industries and IT Minister D. Sridhar Babu’s office said in a release.

Total employment opportunities more than 22,300

Consequently, total investment commitments in the Green Pharma City stands at ₹11,100 crore with employment opportunities, through the projects, at more than 22,300, it said.

MSD’s global technology centre in Hyderabad

Without specifying the investment or details of the proposed facility, the Minister’s office said the Telangana Government welcomed global drug major MSD to the vibrant ecosystem of Telangana. A spokesperson for MSD said “we can confirm that MSD is in the initial stages of establishing a global technology centre in Hyderabad.”

The facility will be MSD’s fifth tech centre globally. The decision to set up the facility aligns with “our commitment to innovation and leveraging advanced technologies to enhance our operations and improve patient outcomes. Further details will be shared as we make progress,” the spokesperson said in a statement.

U.S. firm Agilisium is another company investing in Telangana with the launch of the Life Sciences and Innovation and Talent Development Lab in Hyderabad.

Next phase of manufacturing activity in Telangana to centre in region between ORR and RRR: Industries Secretary 

Global leader in testing, inspection, certification and verification solutions ALS is establishing a biopharma cGMP testing lab in Genome Valley, the Life Sciences cluster near Hyderabad. Lotus company Meishi Pharma is setting up its second research and development centre in Hyderabad under a new Indian subsidiary.

On the strategic partnerships, the Minister’s office said the University of Queensland and Telangana Life Sciences have signed a letter of intent to collaborate on cutting-edge research, digital healthcare, and AI-driven innovations. Indian Digital Health Activator, a first-of-its-kind initiative by the World Economic Forum to accelerate public-private collaboration in digital health, has decided to make Telangana the first Hub under the Activator framework. The focus will be on bridging supply and demand side gaps, creating opportunities for a robust digital health ecosystem.

Under another partnership, the Innovative Pharmaceutical Services Organization (IPSO) will shape the future of the Contract, Research, Development and Manufacturing Organisation (CRDMO) industry. Eleven contract research and development organisations have come together to advance industry needs, collaborate with the government for a favourable regulatory environment, nurture world-class talent and strengthen the supply chain ecosystem. I Health Innovation Manchester has formed a partnership with T-Hub to drive innovation in healthcare, medtech, diagnostics and digital health solutions to enhance patient outcomes and advance cutting edge healthcare solutions.